Skip to main content
SpringerLink
Log in

Can next-generation sequencing reduce costs in clinical practice?

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was funded by Roche Diagnostics SpA.

Reference

  • Pruneri G, et al. Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? PharmacoEconomics-Open : 4 Mar 2021. Available from: URL: https://doi.org/10.1007/s41669-020-00249-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Can next-generation sequencing reduce costs in clinical practice?. PharmacoEcon Outcomes News 874, 11 (2021). https://doi.org/10.1007/s40274-021-7554-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7554-x

Search

Navigation